Who's a Good Candidate (And Who Isn't) In my practice in Southlake, I think about AOD-9604 candidacy in a few specific scenarios
In the research literature, BPC-157 has been studied using several delivery methods, including subcutaneous injection, intramuscular injection, oral administration, and even topical application
Additionally, AOD 9604 is generally considered safe for short-term use, but long-term safety has not been thoroughly established
Venta ilegal: No se puede vender legalmente para consumo humano en la UE, EEUU ni en la mayora de pases
Predrag Sikiric, the lead researcher at the University of Zagreb who has published extensively on BPC-157, stated: "BPC-157 interacts with the NO system as a novel mediator of Robert's cytoprotection, maintaining endothelial integrity across multiple organ systems" [1]